This included cells from biopsies of fibroadenoma and phyllodes fibroepithelial neoplasms, which are benign breast tumors [13]; cells from malignant breast tumors classified on the expression of estrogen (ER) and progesterone (PR) receptors; and HER2 classified into ER+, HER2+, subtypes luminal A and B, and HER2+ [14, 15]. Here, ERBB2 is linked to breast cancer.